A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
Clinical trial NCT01566162 · COMPLETED
Trial details
- NCT number
- NCT01566162
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-11-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.